Most Recent
A court has approved a $2.9 million penalty against medical booking platform HealthEngine after the company admitted to deleting and altering unfavourable reviews and misusing consumer data.
The son of a 92-year-old woman who died after she contracted COVID-19 at a Melbourne aged care home has launched a class action against the residential facility, claiming damages for stress and anxiety caused by his mother’s death.
A former QRx Pharma director's prediction that shareholders would not receive "anything of consequence" from a class action settlement has proven true, with only a small slice of the $7 million settlement expected to go to shareholders.
ASX-listed generic drug maker Mayne Pharma is facing a possible shareholder class action over disclosures related to US price-fixing allegations against the ASX-listed company.
Health booking company HealthEngine has urged the court to accept a $2.9 million penalty for deleting and altering unfavourable reviews, telling a judge that it did not know the behaviour was against the law.
After "unavoidable delays", shareholders will soon be notified of a settlement reached one year ago in a class action against QRxPharma, but a company director has warned group members will receive nothing of consequence and the law firm and funder involved in the case would be disappointed by their takeaways.
AFT Pharmaceuticals has suffered another blow over its Maxigesic advertisements, with a judge finding the marketing material misled consumers by claiming to provide better, faster and more effective pain relief than paracetamol or ibuprofen.
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.
Veterinary pharmaceutical company Norbrook Laboratories has filed court proceedings after a delegate of IP Australia tossed its opposition to a patent by Bayer New Zealand for a bovine antiseptic treatment.
Brisbane clothing company Lorna Jane has been fined almost $40,000 for implying that its 'anti-virus activewear' prevents against infectious diseases such as COVID-19.